• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Document › Details

bioMérieux S.A.. (7/18/18). "Press Release: Second-Quarter 2018 Business Review".

	Organisation	bioMérieux S.A. (Euronext: BIM)
	Group	Mérieux (Group)
	Product	in vitro diagnostics (IVD)
	Product 2	molecular diagnostics
	Person	Mérieux, Alexandre (Mérieux 201712– CEO at bioMérieux before Deputy CEO before VP Industrial Microbiology)

> Strong sales dynamic confirmed in second quarter, leading to sales up 10.4% over the first half at constant exchange rates and scope of consolidation:

>> €1,169 million in sales

>> Up 3.1% as reported


> Growth driven by robust molecular biology and microbiology lines and by industrial applications.


Alexandre Mérieux, Chairman and Chief Executive Officer, said: “After a first quarter in which sales were particularly high due to the flu season, the second quarter of 2018 was another period of strong sales performance for bioMérieux with organic growth of 8.4%. The Group’s balanced and diversified geographic footprint and its comprehensive offering based on three key technologies of in vitro diagnostics were major factors in its success in the second quarter.”

[ Full Release at http://www.biomerieux.com/sites/corporate/files/news-event-press-release/biomerieux_pr_sales_q2_2018.pdf ]

Record changed: 2018-08-22

Advertisement

More documents for Mérieux (Group)

• [1] bioMérieux S.A.. (2/7/19). "Press Release: bioMérieux Acquires Invisible Sentinel, a US-based Company Specialized in Food and Beverage Molecular Testing". Marcy l’Étoile....
• [2] bioMérieux S.A.. (11/13/18). "Press Release: bioMérieux Launches the BioFire FilmArray Pneumonia Panels with FDA Clearance and CE Marking". Marcy l’Étoile....
• [3] bioMérieux S.A.. (11/9/18). "Press Release: bioMérieux Acquires a Majority Stake in Hybiome and Strengthens Its Presence Both in China and in the Immunoassay Market". Marcy l’Étoile....
• [4] bioMérieux S.A.. (5/31/18). "Press Release: bioMérieux Launches Endozyme II GO, an Innovative Test for the Detection of Endotoxins in Pharmaceutical Microbiology Control". Marcy l’Étoile....
• [5] bioMérieux S.A.. (4/19/18). "Press Release: bioMérieux – First-Quarter 2018 Business Review"....
• [6] bioMérieux S.A.. (4/19/18). "Press Release: bioMérieux Submits for FDA Clearance of the Biofire Filmarray Pneumonia Panel". Marcy l’Étoile....
• [7] bioMérieux S.A.. (4/4/18). "Press Release: bioMérieux Reinforces Its Offering of High Medical Value Immunoassay Biomarkers with the Acquisition of Astute Medical". Marcy l’Étoile....
• [8] bioMérieux S.A.. (2/28/18). "Press Release: 2017 Financial Results"....
• [9] bioMérieux S.A.. (1/23/18). "Press Release: bioMérieux – Fourth-Quarter 2017 Business Review"....
• [10] bioMérieux S.A.. (1/15/18). "Press Release: CNES and bioMérieux Extend Their Collaboration on Aquapad, a Unique Water Quality Testing Tool"....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.